Production (Stage)
Hepion Pharmaceuticals, Inc.
HEPA
$0.0722
$0.009214.60%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.26M | 1.79M | 1.70M | 1.37M | 2.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.28M | 1.20M | 4.46M | 8.50M | 5.18M |
| Operating Income | -1.28M | -1.20M | -4.46M | -8.50M | -5.18M |
| Income Before Tax | -6.11M | -1.55M | -4.87M | -3.93M | -5.82M |
| Income Tax Expenses | -- | 0.00 | -- | -- | -2.97M |
| Earnings from Continuing Operations | -6.11M | -1.55M | -4.87M | -3.93M | -2.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.11M | -1.55M | -4.87M | -3.93M | -2.85M |
| EBIT | -1.28M | -1.20M | -4.46M | -8.50M | -5.18M |
| EBITDA | -1.27M | -1.20M | -4.46M | -8.50M | -5.15M |
| EPS Basic | -2.15 | -11.11 | -36.21 | -33.84 | -28.13 |
| Normalized Basic EPS | -0.29 | -11.75 | -22.94 | -45.56 | -47.77 |
| EPS Diluted | -2.15 | -11.11 | -36.21 | -33.84 | -28.13 |
| Normalized Diluted EPS | -0.29 | -11.75 | -22.94 | -45.56 | -47.77 |
| Average Basic Shares Outstanding | 2.84M | 139.30K | 134.40K | 116.00K | 101.50K |
| Average Diluted Shares Outstanding | 2.84M | 139.30K | 134.40K | 116.00K | 101.50K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |